MiniMed to begin trading on Nasdaq Global Select Market

MiniMed Group (Nasdaq: MMED) began trading March 6, 2026 on the Nasdaq Global Select Market following an oversubscribed IPO.

Rhea-AI Summary

MiniMed Group (Nasdaq: MMED) began trading March 6, 2026 on the Nasdaq Global Select Market following an oversubscribed IPO.

The offering was described as the second largest IPO in medtech history and positions MiniMed to operate as a standalone company, while supporting Medtronic (NYSE: MDT)'s capital-focus strategy amid geopolitical market uncertainty.

Positive

• MiniMed began trading on Nasdaq Global Select Market under ticker MMED
• Offering was oversubscribed, indicating strong investor demand
• Described as the second largest IPO in medtech history
• Transaction supports Medtronic refocusing capital toward long‑term value creation

Negative

• Offering occurred amid a challenging market backdrop driven by geopolitical uncertainty

Argus Mar 6 session

-2.27% close to close Open Argus

Details

News Market Reaction – MDT

On Mar 6, the day this news came out, MDT closed 2.27% below the previous close.

Data tracked by StockTitan Argus for the Mar 6 session.

Key Figures

Global employees: 95,000+ people Countries served: 150+ countries Health conditions treated: 70 conditions +1 more

Global employees

95,000+ people

Medtronic global workforce description

Countries served

150+ countries

Geographic footprint of Medtronic operations

Health conditions treated

70 conditions

Number of health conditions Medtronic technologies and therapies address

Patient impact rate

Two people every second

Stated rate at which Medtronic technologies impact patients

Historical Context

5 past events · Latest: Mar 03

5 events

1. Mar 03

   Investor conferences update

   24h Move

   -1.4%

   CFO scheduled for fireside chats at two March investor conferences.

2. Feb 25

   Product launch EMEA

   24h Move

   -0.1%

   EMEA commercial launch of MiniMed Go Smart MDI system with Simplera sensor.

3. Feb 24

   MiniMed IPO roadshow

   24h Move

   -1.9%

   MiniMed IPO roadshow with defined share offering and ownership structure.

4. Feb 17

   Q3 FY26 earnings

   24h Move

   -3.1%

   Strong Q3 results with revenue growth and reiterated FY26 guidance.

5. Feb 17

   Robotics milestone

   24h Move

   -3.1%

   First U.S. commercial surgery using Hugo robotic-assisted surgery system.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

initial public offering, nasdaq global select market, ticker symbol, insulin pumps, +1 more

5 terms

initial public offering financial

"under the ticker symbol "MMED" in connection with its initial public offering"

An initial public offering (IPO) is when a private company first sells its shares to the public and becomes a stock-listed company. It matters because it allows the company to raise money from a wide range of investors, helping it grow, while giving early shareholders a way to sell some of their ownership.

nasdaq global select market financial

"will begin trading today on the Nasdaq Global Select Market (Nasdaq)"

A Nasdaq Global Select Market listing is the highest tier of stocks on the Nasdaq exchange, reserved for companies that meet the strictest financial, reporting and governance standards. For investors, it acts like a premium quality label—signaling larger, more transparent and better-governed companies that tend to offer greater liquidity and lower perceived risk compared with lower-tier listings, making it easier to buy, sell and evaluate shares.

ticker symbol financial

"on the Nasdaq Global Select Market (Nasdaq) under the ticker symbol "MMED""

A ticker symbol is a short, unique code of letters or characters that identifies a publicly traded security on an exchange — like a car’s license plate or a person’s nickname for the market. Investors use ticker symbols to look up live prices, place trades, and follow news; using the correct symbol makes sure you’re tracking or buying the intended stock, bond, or fund and helps avoid costly mix-ups.

View in glossary

insulin pumps medical

"include cardiac devices, surgical robotics, insulin pumps, surgical tools"

Insulin pumps are small wearable devices that deliver measured doses of insulin under the skin throughout the day to help people with diabetes keep their blood sugar within target ranges. They matter to investors because they represent a recurring-revenue medical device market driven by device sales, disposable supplies, and software services, with value tied to regulatory approvals, insurance coverage, clinical benefits and patient adoption — like a programmable, ongoing delivery system replacing manual injections.

patient monitoring systems medical

"surgical tools, patient monitoring systems, and more."

Systems that continuously measure and display patients’ vital signs and other health data — such as heart rate, blood pressure, oxygen levels and temperature — using connected devices and software. Like a dashboard in a car, they give clinicians real‑time alerts and trends so problems can be spotted and treated sooner; for investors, they matter because their adoption affects recurring revenue, hospital purchasing decisions, regulatory risk, and long‑term clinical partnerships.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

GALWAY, Ireland, March 6, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced that MiniMed Group, Inc. (Nasdaq: MMED) will begin trading today on the Nasdaq Global Select Market (Nasdaq) under the ticker symbol "MMED" in connection with its initial public offering ("IPO").

"Today marks an exciting milestone for both MiniMed and Medtronic. Despite a challenging market backdrop shaped by geopolitical uncertainty, the teams successfully executed an oversubscribed offering and the second largest IPO in Medtech history," said Geoff Martha, Medtronic chairman and chief executive officer. "Establishing MiniMed as a standalone entity positions the company to operate with greater agility over the long term. At the same time, this transaction supports Medtronic's strategy to focus capital and resources on long term value creation opportunities that leverage our scale, synergies, and core competencies. We congratulate Que Dallara and our Diabetes colleagues whose leadership and dedication made this moment possible."

About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic (NYSE: MDT), visit www.Medtronic.com and follow Medtronic on LinkedIn.

Medtronic Contacts

Justin Paquette
Public Relations
+1-612-271-7935

Ingrid Goldberg
Investor Relations
+1-763-505-2696

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/minimed-to-begin-trading-on-nasdaq-global-select-market-302706699.html

SOURCE Medtronic plc

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does MiniMed (MMED) beginning trading on Nasdaq mean for investors?

MiniMed (MMED) is now an independent, publicly traded company on Nasdaq Global Select Market. According to the company, the IPO creates standalone equity for MiniMed while allowing Medtronic (MDT) to reallocate capital and focus on long-term value creation.

Was the MiniMed IPO oversubscribed and how significant was it for medtech?

Yes, the IPO was oversubscribed and ranked as the second largest in medtech history. According to the company, strong demand enabled the successful execution despite a challenging geopolitical market backdrop.

How does the MiniMed IPO affect Medtronic (MDT)'s strategy and capital allocation?

Medtronic says the transaction lets it concentrate capital and resources on core opportunities. According to the company, spinning off MiniMed supports a strategy to leverage scale and synergies while focusing on long-term value creation.

What ticker symbol will MiniMed trade under and when did trading start?

MiniMed will trade under the ticker MMED on the Nasdaq Global Select Market. According to the company, trading began on March 6, 2026 following the completion of its initial public offering.

Who leads MiniMed and which Medtronic executives commented on the IPO?

Que Dallara and the Diabetes leadership team were recognized for leading MiniMed. According to the company, Medtronic CEO Geoff Martha commented on the milestone and the strategic rationale for the transaction.